CTMC
Manufacturing · Texas, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2130 W Holcombe Blvd, Houston, Texas, 77...Phone Number
(832) 403-3544Website
www.ctmc.comRevenue
$35.3 MillionIndustry
About CTMC
CTMC Org Chart
Is CTMC your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if CTMC has recently received funding, and reach out quickly before it becomes old news!
Check out if CTMC is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at CTMC
Product Launch: Get notified when CTMC launches new products
Earning: See what the market has to say on CTMC recently announced quarterly report
Website visits: Recent activity has been detected on your website
CTMC, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once CTMC has new funding data
Click to see if CTMC had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at CTMC
Find more new buyers
Compare Similar Companies to CTMC
Compare insights from companies similar to CTMC, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CTMC is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
CTMC is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about CTMC.
CTMC Tech Stack
A closer look at the technologies used by CTMC
Most Recent Scoops
CTMC News & Media
CTMC and Syenex Launch Partnership to Accelerate Scalability of Cell Therapies
HOUSTON & CHICAGO--(BUSINESS WIRE)--CTMC, a joint venture between MD Anderson Cancer Center and Resilience, has entered a partnership with Syenex to advance the scalability and efficiency of engineered T cell therapies. Through this collaboration, CTMC will gain access to Syenex’s bioengineering systems, which provide a significant improvement in gene delivery efficiency and engineering timelines. Jason Bock, CEO of CTMC, stated, “Our mission is to accelerate the delivery of transformative cellOri Biotech and CTMC Present Scientific Data for New IRO® Platform at ISCT 2024
Ori Biotech and CTMC announce promising results for IRO, Ori’s newly launched next-generation CGT manufacturing enabling platform.KSQ Therapeutics and CTMC Announce Strategic Collaboration to Accelerate the Development of Novel Engineered Tumor Infiltrating Lymphocyte (eTIL®) Therapies for the Treatment of Solid Tumors
LEXINGTON, Mass.--(BUSINESS WIRE)--KSQ Therapeutics, Inc. ("KSQ"), a clinical-stage biotechnology company developing cancer therapies using its proprietary CRISPRomics® discovery platform, and CTMC, a joint venture between National Resilience, Inc. and MD Anderson Cancer Center, announced today a strategic collaboration to expedite the development of KSQ's two lead engineered tumor-infiltrating lymphocyte (eTIL®) programs, KSQ-001EX and KSQ-004EX, both of which are advancing toward clinical stuCTMC Marks One Year of Accelerating Life-Saving Cell Therapies to Patients
HOUSTON--(BUSINESS WIRE)--CTMC, a joint venture between MD Anderson Cancer Center and Resilience, celebrates one year since its founding to accelerate life-saving cell therapies reaching patients. During its first year, CTMC has partnered with MD Anderson investigators and biotech companies to bring several novel cell therapies through Investigational New Drug (IND)-enabling studies and U.S. Food and Drug Administration (FDA) interactions to initiate clinical development. “Our team and partners
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CTMC
CTMC specializes in accelerating the development of cell therapies from research to clinical application through its advanced manufacturing capabilities and collaborative partnerships. The company offers a fully integrated 360 Solutions model that combines development, manufacturing, and regulatory support to streamline the path to patient access.... Read More